Pinetree Therapeutics
PrivateLast Round
Series B
Oct 28, 2025
Total Funding Raised
$47M
Momentum Score
25 /100
Company Overview
Pinetree Therapeutics is a biotechnology company developing transformative therapies through targeted protein degradation for oncology and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pinetree Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Pinetree Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 28, 2025 |
Pinetree Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series B |
| DSC Investment | Series B |
| Smilegate Investment | Series B |
| S&S Investment | Series B |
| SJ Investment Partners | Series B |
| Samho Green Investment | Series B |
| Korea Investment Partners | Series B |
Pinetree Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pinetree Therapeutics's valuation, stock price, and market status.
